Molecular Pharmacology (USA), Ltd.
MLPH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 6/30/2014 | |
|---|---|---|---|---|
| Market Cap | $100 | $300 | $11 | $1,116 |
| - Cash | $0 | $0 | $0 | $2 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $100 | $300 | $11 | $1,113 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$901 | -$8 | -$117 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$901 | -$8 | -$117 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0.001 | -0 | -0.001 |
| % Growth | 100% | -800% | 90% | – |
| Operating Cash Flow | – | – | – | -$105 |
| Capital Expenditures | – | – | – | $0 |
| Free Cash Flow | – | – | – | -$105 |